AUSTIN, Texas, Aug. 30, 2018 /PRNewswire/ -- Timicoin/TimiHealth (www.timicoin.io), the leader in genetic data ownership through its ultra secureblockchain technology is urging consumers to petition genetic testing companies like 23andMe to provide complete transparency in how they use collected genetic data and allow portability to whomever individual consumers choose to have it.
TimiHealth launched the TimiDNA platform as a direct response to 23andMe and other genetic testing companies who are selling genetic data for unintended financial benefit without the understood permission of consumers or profit sharing with them.
This was highlighted by the announced $300 million dollar 50/50 partnership deal between 23andMe and GlaxoSmithKline (GSK) (https://www.gsk.com/en-gb/media/press-releases/gsk-and-23andme-sign-agreement-to-leverage-genetic-insights-for-the-development-of-novel-medicines). It was futher exacerbated by the restrictions placed on their API program as described by the following statement sent to consumers:
"Moving forward, we've decided to restrict our API to only work with select applications that will use the data based on 23andMe reports to bring added value to your overall experience. Based on these changes, in two weeks, we will be disabling other apps' ability to access your data using the 23andMe API, and any features in those third-party apps that rely on your 23andMe data may no longer work."
TimiHealth is supporting consumers who have expressed deep disappointment and anger in the misrepresentation of services for the collection and sale of their genetic DNA data through sponsorship of "Where's Your DNA? Petition at www.wheresyourdna.com.
If you are an affected genetic consumer who believes you should own and control your DNA data and have the right to participate in the financial sale of your data if you so choose, sign the petition and have your voice heard. Nothing defines you more than your DNA and understanding how it is being used or sold is paramount to the issue of personal data security.
"TimiHealth is fighting for consumer rights and individual data ownership and will continue to offer avenues for consumers to secure the most sensitive data one can possess in ourblockchain solution," said Timicoin/TimiHealth.
The Blockchain-as-a-Service Platform provides decentralized healthcare data which can be accessed instantly from anywhere. Timicoin/TimiHealth (Timicoin.io) is a patent-pending solution to securing patient data, while providing unprecedented portability. The company is actively deploying pilot programs in the US, Mexico City and Monterrey, Mexico.
Media Contact: Adrienne Mazzone 561-750-9800 x2270; firstname.lastname@example.org